APA (7th ed.) Citation

TTG, L., J, Y., JS, H., YJ, K., WB, J., THV, L., . . . SM, K. (2026). Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944. International journal of molecular sciences, 27(7), . https://doi.org/10.3390/ijms27073216

Chicago Style (17th ed.) Citation

TTG, Ly, et al. "Correction: Ly Et Al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944." International Journal of Molecular Sciences 27, no. 7 (2026). https://doi.org/10.3390/ijms27073216.

MLA (9th ed.) Citation

TTG, Ly, et al. "Correction: Ly Et Al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944." International Journal of Molecular Sciences, vol. 27, no. 7, 2026, https://doi.org/10.3390/ijms27073216.